It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
... to authorize use of COMIRNATY (COVID-19 Vaccine, mRNA) under this EUA for certain uses that are not included in the approved BLA.
Additionally, as specified in subsection III.BB, I am authorizing use of COMIRNATY (COVID-19 Vaccine, mRNA) under this EUA when used to provide a two-dose regimen for individuals aged 12 through 15 years, or to provide a third dose to individuals 12 years of age or older who have undergone solid organ transplantation or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.
The licensed vaccine has the same formulation as the EUA-authorized vaccine and the products can be used interchangeably to provide the vaccination series without presenting any safety or effectiveness concerns.
On August 23, 2021, FDA approved the biologics license application (BLA) submitted by BioNTech Manufacturing GmbH for COMIRNATY (COVID-19 Vaccine, mRNA) for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 16 years of age and older.
originally posted by: Vector99
What isn't true?
Israel having a high percentage of vaccinated people
Israel having an outbreak of covid
Which one was I wrong on?
originally posted by: Vector99
Can you link me to that story? Because when a treatment gets full FDA approval, all the other emergency use treatments are no longer allowed due to there being an approved treatment.
originally posted by: Vasa Croe
originally posted by: Zitterbewegung
a reply to: nonspecific
The CDC has been telling pregnant women to get the vaccine. How can they do that knowing there was barely any testing done on fertility. None in men and none on breastfeeding and birth defects.
Except for a few rats.....
Because the people are the tests....kind of like most democratic bills, you have to take the vaccine to see what it does.
nder section 564 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), when the Secretary of HHS declares that an emergency use authorization is appropriate, FDA may authorize unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions caused by CBRN threat agents when certain criteria are met, including there are no adequate, approved, and available alternatives.